¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå : ¿¹Ãø(2025-203³â)
Global Contrast Agent Market - Forecasts fom 2025 to 2030
»óǰÄÚµå : 1800247
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 142 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,559,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,404,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,782,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¶¿µÁ¦ ½ÃÀåÀº CAGR 7.08%·Î 2025³â 70¾ï 3,800¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 99¾ï 700¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¶¿µÁ¦ ½ÃÀåÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÃÊÀ½ÆÄ, ¿¢½º·¹ÀÌ, MRI, CT µî ¿µ»óÁø´Ü ¼ö¿ä Áõ°¡·Î ÀÎÇØ 2025³âºÎÅÍ 2030³â±îÁö Å« ÆøÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. Á¶¿µÁ¦´Â ÀǷ῵»óÁø´Ü¿¡¼­ ¿µ»óÀÇ ¼±¸íµµ¸¦ ³ôÀ̴µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ƯÈ÷ ¿µ»óÀ¯µµ¼ú(IGS)¿¡¼­ Á¤È®ÇÑ Áø´Ü°ú Ä¡·á¸¦ Áö¿øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº À̹Ì¡ ±â¼ú ¹ßÀü, ÇコÄɾî ÅõÀÚ È®´ë, Çõ½ÅÀûÀÎ Á¶¿µÁ¦ ¿¬±¸°³¹ß ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì°¡ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖÁö¸¸, ¾ÆÅÂÁö¿ªÀº ÇコÄɾî ÀÎÇÁ¶ó È®´ë·Î ÀÎÇØ ±Þ°ÝÇÑ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ³ôÀº ºñ¿ë°ú Á¶¿µÁ¦ÀÇ ÀáÀçÀû ºÎÀÛ¿ë µîÀÌ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¸¸¼ºÁúȯ Áõ°¡

¾Ï, ½ÉÇ÷°ü Áúȯ, ´ç´¢º´°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Á¶¿µÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¹Ì±¹ ¾Ï Çùȸ´Â 2023³â ¹Ì±¹ ³» ³²¼º ½Å±Ô ¾Ï ȯÀÚ 101¸¸ 3,310¸í, ¿©¼º ½Å±Ô ¾Ï ȯÀÚ 94¸¸ 8,000¸íÀÌ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, À̴ ÷´Ü Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á¸¦ À§Çؼ­´Â Áø´Ü°ú Ä¡·á °èȹÀ» À§ÇÑ Á¤¹ÐÇÑ ¿µ»óÁø´ÜÀÌ ÇÊ¿äÇϸç, CT, MRI °Ë»ç µî Á¶¿µÁ¦ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µ¿¹ÝÁúȯÀÇ À¯º´·üÀÌ ³ô¾Æ ¿µ»óÁø´Ü ±â´ÉÀÇ °­È­°¡ ÇÊ¿äÇϸç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿µ»óÁø´Ü ¼ö¿ä Áõ°¡

CT³ª MRI¿Í °°Àº ¿µ»óÁø´Ü¿¡ ´ëÇÑ »çȸÀû Àνİú Á¢±Ù¼º Çâ»óÀ¸·Î ¿µ»óÁø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϸ鼭 Á¶¿µÁ¦ ½ÃÀå¿¡ Ȱ·ÂÀ» ºÒ¾î³Ö°í ÀÖ½À´Ï´Ù. ¿µ»ó°¡À̵åÇϼö¼úÀº ½Ç½Ã°£ ½Ã°¢È­°¡ °¡´ÉÇÏ¿© ¼ö¼ú ¼ºÀû°ú Áø´ÜÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. µî»ïÅõ¾ÐÁ¦¿Í °°Àº Á¶¿µÁ¦ÀÇ ±â¼ú Çõ½ÅÀº ¿µ»óÀÇ Áú°ú ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ô¿© ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À¼ö¼úÀÇ º¸±ÞÀ¸·Î Á¤È®ÇÑ Áø´ÜÀ» À§ÇÑ Á¶¿µÁ¦ÀÇ Çʿ伺ÀÌ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¿¬±¸°³¹ß¿¡ ´ëÇÑ ³ë·Â °­È­

¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â »õ·Î¿î Á¶¿µÁ¦ ÀÀ¿ë ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±â¾÷, ¿¬±¸±â°ü, Çмú±â°üÀÇ Çù·ÂÀ¸·Î ºÎÀÛ¿ëÀÌ Àû°í ¾ÈÀüÇϰí È¿°úÀûÀÎ Á¶¿µÁ¦ °³¹ßÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº ÷´Ü MRI ¹× ½ºÆåÆ®·³ CT ¿µ»ó°ú °°Àº »õ·Î¿î ÀÀ¿ë ºÐ¾ß¿¡¼­ Á¶¿µÁ¦ »ç¿ëÀ» È®´ëÇÏ¿© ¹ÌÃæÁ·µÈ ÀÓ»óÀû ¿ä±¸¸¦ ÃæÁ·½Ã۰í ȯÀÚ °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¶¿µÁ¦ ½ÃÀåÀº °íµµÀÇ ¿µ»óó¸®¿Í ³ôÀº Á¶¿µÁ¦ ºñ¿ëÀ̶ó´Â ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÁ¤ Á¶¿µÁ¦¿Í °ü·ÃµÈ ¾Ë·¹¸£±â ¹ÝÀÀ ¹× ½Åµ¶¼º µîÀÇ ÀáÀçÀû ºÎÀÛ¿ëÀº ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°¸ç, ¾ö°ÝÇÑ Å×½ºÆ®¿Í ±ÔÁ¦ Áؼö°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, °ø±Þ¸ÁÀÇ Á¦¾à°ú ±ÔÁ¦ÀÇ º¹À⼺ÀÌ ½ÃÀåÀÇ È®À强À» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ ±â¼ú Çõ½Å°ú º¸´Ù ¾ÈÀüÇÑ Á¦ÇüÀ» ÅëÇØ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀÌ Áö¼Ó °¡´ÉÇÑ ¼ºÀå¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

Á¦3Àå ºñÁî´Ï½º »óȲ

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå : ¸ð´Þ¸®Æ¼º°

Á¦7Àå ¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå : Åõ¿© °æ·Îº°

Á¦8Àå ¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå : ÀûÀÀÁõº°

Á¦9Àå ¼¼°èÀÇ Á¶¿µÁ¦ ½ÃÀå : Áö¿ªº°

Á¦10Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global contrast agent market is expected to grow from USD 7.038 billion in 2025 to USD 9.907 billion in 2030, at a CAGR of 7.08%.

The global contrast agent market is poised for significant growth from 2025 to 2030, driven by the rising prevalence of chronic diseases and increasing demand for diagnostic imaging procedures such as ultrasonography, X-rays, MRI, and CT scans. Contrast agents, critical for enhancing image clarity in medical imaging, support accurate diagnosis and treatment, particularly in image-guided procedures (IGS). The market is propelled by advancements in imaging technology, growing healthcare investments, and rising R&D initiatives for innovative contrast agents. North America holds a significant market share, while Asia-Pacific is expected to grow rapidly due to expanding healthcare infrastructure. Challenges include high costs and potential adverse effects of contrast agents.

Market Drivers

Rising Prevalence of Chronic Diseases

The increasing incidence of chronic conditions, such as cancer, cardiovascular diseases, and diabetes, is a primary driver of the contrast agent market. In 2023, the American Cancer Society reported 1,010,310 new cancer cases in males and 948,000 in females in the United States, highlighting the growing need for advanced diagnostic tools. Conditions like these require precise imaging for diagnosis and treatment planning, boosting demand for contrast agents in procedures like CT and MRI scans. The high prevalence of comorbidities necessitates enhanced imaging capabilities, further driving market growth.

Growing Demand for Diagnostic Imaging

The surge in demand for diagnostic imaging, driven by public awareness and improved accessibility to modalities like CT and MRI, is fueling the contrast agent market. Image-guided procedures are gaining popularity due to their ability to provide real-time visualization, improving surgical outcomes and diagnostic accuracy. Innovations in contrast media, such as iso-osmolar agents, enhance imaging quality and patient safety, supporting market expansion. The growing adoption of minimally invasive procedures further amplifies the need for contrast agents to ensure precise diagnostics.

Rising R&D Initiatives

Increased investment in research and development is creating opportunities for novel contrast agent applications. Collaborative efforts between companies, research institutions, and academic bodies are focused on developing safer, more effective agents with fewer side effects. These initiatives aim to expand the use of contrast agents in emerging applications, such as advanced MRI and spectral CT imaging, driving market growth by addressing unmet clinical needs and improving patient outcomes.

Market Restraints

The contrast agent market faces challenges due to the high cost of advanced imaging procedures and contrast media, which can limit accessibility in cost-sensitive regions. Potential adverse effects, such as allergic reactions or nephrotoxicity associated with certain contrast agents, pose safety concerns, necessitating rigorous testing and regulatory compliance. Additionally, supply chain constraints and regulatory complexities may hinder market scalability. Addressing these challenges through cost-effective innovations and safer formulations will be critical for sustained growth.

Market Segmentation

By Type

The market is segmented into iodinated, gadolinium-based, barium-based, and microbubble contrast agents. Iodinated agents dominate due to their widespread use in CT imaging, while gadolinium-based agents are critical for MRI scans. Microbubble agents are gaining traction in ultrasound imaging for their ability to enhance vascular visualization.

By Application

The market includes diagnostic imaging (CT, MRI, ultrasound) and image-guided procedures. Diagnostic imaging holds the largest share, driven by the rising need for accurate diagnosis in chronic disease management. Image-guided procedures are a fast-growing segment due to their increasing use in minimally invasive surgeries.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads, driven by a robust healthcare sector, high cancer prevalence, and product innovations like Fresenius Kabi's FDA-approved generic iodixanol contrast agent launched in 2023. Asia-Pacific is expected to grow rapidly, fueled by expanding healthcare infrastructure and rising chronic disease rates in countries like China and India.

The contrast agent market is set for robust growth from 2025 to 2030, driven by the rising prevalence of chronic diseases, increasing demand for diagnostic imaging, and R&D advancements. Despite challenges like high costs and safety concerns, the market's outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on developing safer, cost-effective agents and leveraging collaborations to meet the growing demand for advanced imaging solutions.

Key Benefits of this Report:

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Segmentation:

By Type

By Modality

By Route of Administration

By Indication

By Geography

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

3. BUSINESS LANDSCAPE

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CONTRAST AGENT MARKET BY TYPE

6. GLOBAL CONTRAST AGENT MARKET BY MODALITY

7. GLOBAL CONTRAST AGENT MARKET BY ROUTE OF ADMINISTRATION

8. GLOBAL CONTRAST AGENT MARKET BY INDICATION

9. GLOBAL CONTRAST AGENT MARKET BY GEOGRAPHY

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

11. COMPANY PROFILES

12. RESEARCH METHODOLOGY

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â